According to this New York Times article, the genetic repair process CRISPR may make it possible for pig hearts to replace human hearts. If this technology works, it would be good news for those awaiting transplant.
Currently, there are limited organs available with strict protocols for eligibility. A new source of suitable donor organs would be a great advance for heart transplantation.
There are distinct stages of HCM and treatments will vary according to the stage. Therefore, it is important, according to a recent article in the Netherlands Heart Journal, for patients to seek treatment from teams experienced in the the treatment of HCM. These professionals are able to recognize transitions in the course of the disease as they occur, and then implement necessary changes in treatment.
In this thorough overview of HCM and its treatment, Dr. Iacopo Olivotto and his colleagues in the Netherlands observe that HCM is seen infrequently by community cardiologists (as compared to more common heart conditions like coronary artery disease). Hence, one of the major difficulties in HCM practice has been identification of patients at highest risk.
Continue reading “One Size Does NOT Fit All: Treatments Differ by Stage in HCM”